WO2013030794A3 - Use of substituted pyridines as skin depigmenting compounds - Google Patents
Use of substituted pyridines as skin depigmenting compounds Download PDFInfo
- Publication number
- WO2013030794A3 WO2013030794A3 PCT/IB2012/054488 IB2012054488W WO2013030794A3 WO 2013030794 A3 WO2013030794 A3 WO 2013030794A3 IB 2012054488 W IB2012054488 W IB 2012054488W WO 2013030794 A3 WO2013030794 A3 WO 2013030794A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- substituted pyridines
- skin depigmenting
- depigmenting compounds
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Abstract
The present invention relates to skin and/or hair depigmentation compositions comprising a pyridine derivative and dermatologically acceptable carriers. The skin and/or hair depigmentation compositions can also comprise cysteamine hydrochloride. The present invention also relates to the cosmetic and pharmaceutical use thereof for reducing skin and/or hair pigmentation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1425/11 | 2011-08-31 | ||
CH14252011 | 2011-08-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013030794A2 WO2013030794A2 (en) | 2013-03-07 |
WO2013030794A3 true WO2013030794A3 (en) | 2013-12-27 |
Family
ID=47116122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2012/054488 WO2013030794A2 (en) | 2011-08-31 | 2012-08-31 | Use of substituted pyridines as skin depigmenting compounds |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013030794A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6880011B2 (en) * | 2015-10-05 | 2021-06-02 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Skin whitening composition |
EP3471692B1 (en) * | 2016-06-15 | 2019-10-30 | Unilever N.V. | Method and cosmetic composition for enhanced transdermal delivery of alkyl substituted resorcinol |
RS58997B1 (en) * | 2018-09-14 | 2019-08-30 | Fazlagic Amira Dr | Composition against aging of the intimate area skin |
WO2021249760A1 (en) | 2020-06-10 | 2021-12-16 | Unilever Ip Holdings B.V. | A cosmetic composition comprising 6-methyl-picolinamide |
WO2021260667A2 (en) | 2020-06-26 | 2021-12-30 | Universidade Do Minho | Composition for hair follicle modulation, methods and uses thereof |
WO2022208123A1 (en) * | 2021-03-30 | 2022-10-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for treating hyperpigmentation disorders |
WO2024056568A1 (en) * | 2022-09-12 | 2024-03-21 | Behrooz Kasraee | Skin depigmentation composition and use thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003057184A2 (en) * | 2001-12-28 | 2003-07-17 | Integriderm, Inc. | Hydroxamic acid and its derivatives as inhibitors of melanocyte tyrosinase for topical skin lighteners |
JP2004123554A (en) * | 2002-09-30 | 2004-04-22 | Pias Arise Kk | Substance for improving skin barrier function, substance for ameliorating skin wrinkle, skin care preparation for external use, cosmetic and quasi-drug comprising the same substance |
EP1649852A1 (en) * | 2003-07-16 | 2006-04-26 | Institute of Medicinal Molecular Design, Inc. | Chromatosis remedies |
US20100015072A1 (en) * | 2008-06-30 | 2010-01-21 | Christopher Polla | Topical Compositions Comprising Isonicotinamide |
-
2012
- 2012-08-31 WO PCT/IB2012/054488 patent/WO2013030794A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003057184A2 (en) * | 2001-12-28 | 2003-07-17 | Integriderm, Inc. | Hydroxamic acid and its derivatives as inhibitors of melanocyte tyrosinase for topical skin lighteners |
JP2004123554A (en) * | 2002-09-30 | 2004-04-22 | Pias Arise Kk | Substance for improving skin barrier function, substance for ameliorating skin wrinkle, skin care preparation for external use, cosmetic and quasi-drug comprising the same substance |
EP1649852A1 (en) * | 2003-07-16 | 2006-04-26 | Institute of Medicinal Molecular Design, Inc. | Chromatosis remedies |
US20100015072A1 (en) * | 2008-06-30 | 2010-01-21 | Christopher Polla | Topical Compositions Comprising Isonicotinamide |
Non-Patent Citations (6)
Title |
---|
"Iproniazid", WIKIPEDIA, 28 July 2013 (2013-07-28), pages 1 - 2, XP055076767, Retrieved from the Internet <URL:http://de.wikipedia.org/wiki/Iproniazid> [retrieved on 20130828], DOI: 10.1016/0006-2952(86)90285-6 * |
ANONYMOUS: "Nialamide", 26 May 2013 (2013-05-26), pages 1 - 2, XP055076772, Retrieved from the Internet <URL:http://en.wikipedia.org/wiki/Nialamide> [retrieved on 20130828], DOI: 10.1111/j.1365-2133.1977.tb15180.x * |
D. G. GRAY ET AL.: "Clinico-Laboratory Studies of Alpha-ethylthioisonicotinamide (TH 1314)", CANAD. MED. ASS. J., vol. 86, 1962, pages 317 - 320, XP055076770 * |
FOURCHE JEANNE ET AL: "INTERFERENCE DE DERIVES DE L'HYDRAZINE SUR LA REACTION TYROSINASE-TYROSINE//Interference of hydrazine derivatives on the tyrosinase-tyrosine reaction", COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L'ACADEMIE DESSCIENCES. SERIES D, SCIENCES NATURELLES, GAUTHIER-VILLARS, PARIS, FR, vol. 287, no. 4, 11 September 1978 (1978-09-11), pages 365 - 368, XP009172100, ISSN: 0567-655X * |
LEIGH MIYAMOTO, JAMES S. TAYLOR: "Chapter 32. Chemical Leukoderma", 2000, Blackwell Science Ltd, Oxford, UK, pages 269 - 280, XP002711905, ISBN: 0-632-05071-3, Retrieved from the Internet <URL:http://onlinelibrary.wiley.com/doi/10.1002/9780470760116.ch32/pdf> * |
S. S. BLEEHEN ET AL.: "Depigmentation of skin with 4-isopropylcatechol, mercaptoamines, and other compounds", THE JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 50, no. 2, 1968, pages 103 - 117, XP002711904 * |
Also Published As
Publication number | Publication date |
---|---|
WO2013030794A2 (en) | 2013-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013030794A3 (en) | Use of substituted pyridines as skin depigmenting compounds | |
PT2734180T (en) | Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities | |
WO2013025765A3 (en) | Methods of reducing odor | |
PL3176156T3 (en) | Alkylamidothiazoles, cosmetic and dermatological preparations containing them, and their use for the treatment and prophylaxis of unwanted pigmentation of the skin | |
HK1141454A1 (en) | A cosmetic composition for skin whitening comprising the extract of magnolia sieboldii as active ingredient | |
PL2549979T3 (en) | Cosmetic or dermatological preparations with a content of one or more thiazole derivatives | |
WO2011122869A3 (en) | Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care | |
EP2797595A4 (en) | A nutritional approach to the use of ergothioneine and vitamin d2 for hair, nail and skin growth | |
PT2552397T (en) | Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate and a vitamin a compound | |
IL231050A0 (en) | Substituted 4,5,6,7-terahydro1h-pyrazolo[4,3-c]pyridines,their use as medicament,and pharmaceutical preparations comprising them | |
PL2758383T3 (en) | Aromatic amidothiazoles, cosmetic and dermatological preparations containing them, and their use for the treatment and prophylaxis of unwanted pigmentation of the skin | |
IT1395122B1 (en) | COMPOSITION FOR PHARMACEUTICAL OR COSMETIC OR DIETETIC USE PERFORMING A HAIR PIGMENTATION EFFECT | |
WO2012116990A3 (en) | Novel use | |
WO2013002518A3 (en) | Skin care kit comprising cosmetic compound and application method for the cosmetic compound | |
WO2012161497A3 (en) | Peptide derivatives having a superior moisturizing effect and uses thereof | |
WO2011021892A3 (en) | Composition for skin improvement comprising hexamidines and retinoids | |
WO2013109388A3 (en) | 1,5-naphthyridine derivatives and melk inhibitors containing the same | |
ZA201500362B (en) | Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient | |
PL2758382T3 (en) | Heterocyclocarbonylaminothiazoles, cosmetic and dermatological preparations containing them, and their use for the treatment and prophylaxis of unwanted pigmentation of the skin | |
PL2593097T3 (en) | Compounds with a skin pigmenting activity and pharmaceutical or cosmetic compositions containing them | |
WO2012020070A3 (en) | Enhancement of the skin depigmentation | |
WO2012128971A3 (en) | Topical acyl glutathione formulations | |
EP2641894A4 (en) | Glycin derivatives inhibiting melanin production and whitening composition thereof | |
WO2008125237A3 (en) | Use of vernonia appendiculata extract for improving the skin status | |
IL225879A0 (en) | Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 31/07/2014) |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 31/07/2014) |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12780534 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12780534 Country of ref document: EP Kind code of ref document: A2 |